What is Viridian Therapeutics, Inc.'s long-term debt?

Viridian Therapeutics, Inc. (VRDN) reported long-term debt of $36.09M in Q1 2026.

How has Viridian Therapeutics, Inc.'s long-term debt changed year-over-year?

Viridian Therapeutics, Inc.'s long-term debt increased by 74.5% year-over-year, from $20.69M to $36.09M.

What does long-term debt mean?

Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.

Viridian Therapeutics, Inc. VRDN Long-Term Debt

Long-Term Debt at other companies

AmgenAMGN

$51.89B-3.9%

ANI PharmaceuticalsANIP

$286M-6.3%

Vera TherapeuticsVERA

$75.03M+47.4%

TG TherapeuticsTGTX

$745.14M+204%

Johnson & JohnsonJNJ

$37.53B-2.2%

BridgeBio PharmaBBIO

——

Other financials

Income statement

See full

Revenue$141.0K+95.8%

Operating income-$116.2M-23.8%

Net income-$104.9M-20.7%

EPS (diluted)-$1.15-5.5%

Balance sheet

See full

Cash & equivalents$176.3M+51.7%

Total debt$36.8M+59.4%

Total equity$636.0M+5.2%

Total assets$789.0M+19.4%

Cash flow

See full

Operating cash flow-$119.7M-29.1%

CapEx$23.0K-73.3%

Free cash flow-$119.7M-29.0%

Valuation

See full

Market cap$1.91B+82.0%

Enterprise value$1.77B+85.0%

P/S26.9×-3,445×

Profitability

See full

Gross margin36.3%—

Operating margin-543.9%-271pp

Net margin-508.5%-254pp

FCF margin-428.4%-214pp

Returns & leverage

See full

Return on equity-58.1%+7.9pp

Debt / equity0.1×0.0×

Current ratio15.1×-4.3×

Where this comes from

Reported directly by Viridian Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherLongTermDebtNoncurrent.

The official record: Viridian Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viridian Therapeutics, Inc.'s long-term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Viridian Therapeutics, Inc.'s long-term debt?: Viridian Therapeutics, Inc. (VRDN) reported long-term debt of $36.09M in Q1 2026.
How has Viridian Therapeutics, Inc.'s long-term debt changed year-over-year?: Viridian Therapeutics, Inc.'s long-term debt increased by 74.5% year-over-year, from $20.69M to $36.09M.
What does long-term debt mean?: Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.